Loading company…
Repertoire Genesis analyzes immune diversity to support disease research, diagnostics, and treatment development.
Founded in 2014 in Japan, Repertoire Genesis uses immune diversity analysis to study diseases and support drug development and tailored treatment selection. Its platform serves universities, research institutes, pharmaceutical and diagnostic companies, and medical providers. The company also researches cell therapies intended to improve treatment cost, efficacy, and safety.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in